Novo's Soerensen Doesn't Plan to Diverge Beyond Diabetes

Feb. 2 (Bloomberg) -- Lars Rebien Soerensen, chief executive officer of Novo Nordisk AS, discusses business strategy for the worlds biggest insulin maker. Soerensen speaks with Shannon Pettypiece on Bloomberg Televisions "InsideTrack." (Source:

Read more ...